Effect of a contraceptive pill containing estradiol valerate and dienogest (E2V/DNG) in women with menstrually-related migraine (MRM)

Contraception

Volumn 88, Issue 3, 2013, Pages 369-375

  Nappi, Rossella E ^a   Terreno, Erica ^a   Sances, Grazia ^a,b   Martini, Ellis ^a   Tonani, Silvia ^a   Santamaria, Valentina ^a   Tassorelli, Cristina ^a,b   Spinillo, Arsenio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Bleeding; Dienogest; Dysmenorrhea; Estradiol valerate; Hormonally associated headaches; Migraine without aura

Indexed keywords

ALMOTRIPTAN; DIENOGEST PLUS ESTRADIOL VALERATE; ELETRIPTAN; ESTROGEN; GESTAGEN; IBUPROFEN; INDOMETACIN; NAPROXEN; RIZATRIPTAN; SUMATRIPTAN;

ADULT; ARTICLE; BIRTH CONTROL; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; FOLLOW UP; HUMAN; MENSTRUAL MIGRAINE; REMISSION;

BLEEDING; DIENOGEST; DYSMENORRHEA; ESTRADIOL VALERATE; HORMONALLY ASSOCIATED HEADACHES; MIGRAINE WITHOUT AURA;

ADULT; ANALGESICS; BODY MASS INDEX; CONTRACEPTIVES, ORAL, COMBINED; DYSMENORRHEA; ESTRADIOL; FEMALE; HUMANS; ITALY; MENSTRUATION; MIGRAINE DISORDERS; NANDROLONE; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84883451417     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2013.02.001     Document Type: Article

References (39)

1. R.E. Nappi, and S.L. Berga Migraine and reproductive life Handb Clin Neurol 97 2010 303 322
2. The international classification of headache disorders, 2nd ed. Cephalalgia 2004;(suppl 1).
3. E.A. MacGregor, and A. Hackshaw Prevalence of migraine on each day of the natural menstrual cycle Neurology 63 2004 351 353
4. W.F. Stewart, R.B. Lipton, and E. Chee Menstrual cycle and headache in a population sample of migraineurs Neurology 55 2000 1517 1523
5. E.A. MacGregor, H. Chia, R.C. Vohrah, and M. Wilkinson Migraine and menstruation: a pilot study Cephalalgia 10 1990 305 310
6. B.W. Sommerville Estrogen-withdrawal migraine Neurology 25 1975 239 244
7. E.G. Couturier, M.A. Bomhof, A.K. Neven, and N.P. van Duijn Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment Cephalalgia 23 2003 302 308
8. F. Granella, G. Sances, and G. Allais Characteristics of menstrual and non-menstrual attacks in women with menstrually-related migraine Cephalagia 24 2004 707 716
9. E.A. MacGregor Migraine and use of combined hormonal contraceptives: a clinical review J Fam Plann Reprod Health Care 33 2007 159 169
10. E.W. Loder, D.C. Buse, and J.R. Golub Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice Headache 45 2005 224 231
11. E.W. Loder, D.C. Buse, and J.R. Golub Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review Am J Obstet Gynecol 193 2005 636 649
12. E.A. MacGregor, A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study Neurology 67 2006 2159 2163
13. R.E. Nappi, G. Sances, and B. Brundu Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval Hum Reprod 20 2005 3423 3428
14. V. De Leo, V. Scolaro, M.C. Musacchio, A. Di Sabatino, G. Morgante, and A. Cianci Combined oral contraceptives in women with menstrual migraine without aura Fertil Steril 96 2011 917 920
15. P.J. Sulak, T.J. Kuehl, M. Ortiz, and B.L. Shull Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms Am J Obstet Gynecol 18 2002 1142 1149
16. A. Calhoun Combined hormonal contraceptives: is it time to reassess their role in migraine? Headache 52 2012 648 660
17. G. Allais, I.C. Gabellari, C. De Lorenzo, O. Mana, and C. Benedetto Oral contraceptives in migraine Expert Rev Neurother 9 2009 381 393
18. R. Burkman, C. Bell, and D. Serfaty The evolution of combined oral contraception: improving the risk-to-benefit ratio Contraception 84 2011 19 34
19. R. Sitruk-Ware, and A. Nath The use of newer progestins for contraception Contraception 82 2010 410 417
20. S. Zeun, M. Lu, A. Uddin, B. Zeiler, D. Morrison, and H. Blode Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest Eur J Contracept Reprod Health Care 14 2009 221 232
21. H.J. Ahrendt, D. Makalová, S. Parke, U. Mellinger, and D. Mansour Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel Contraception 80 2009 436 444
22. I.S. Fraser, T. Römer, S. Parke, S. Zeun, U. Mellinger, and A. Machlitt Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial Hum Reprod 26 2011 2698 2708
23. G. Merki-Feld, G. Macias, S. Parke, U. Mellinger, and M. Serrani Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: comparison of oestradiol valerate/dienogest versus ethinylestradiol/levonorgestrel Eur J Contracept Reprod Health Care 17 S1 2012 ABSTR P092
24. L.K. Mannix Menstrual-related pain conditions: dysmenorrhea and migraine J Womens Health 17 2008 879 891
25. G. Nappi, R. Jensen, R.E. Nappi, G. Sances, P. Torelli, and J. Olesen Diaries and calendars for migraine. A review. Cephalalgia 26 2006 905 916
26. W. Junge, U. Mellinger, S. Parke, and M. Serrani Metabolic and haemostatc effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study Clin Drug Investig 31 2011 573 584
27. U.M. Agren, M. Anttila, K. Maenpaa-Liukko, M.L. Randala, H. Rautiainen, and W.F. Sommer Effects of a monophasic combined oral contracetive containing nomegestrol acetate and 17b-oestradiol compared with one containing levonorgestrel and ethynilestradiol on haemostasis, lipids and carbohydrate metabolism Eur J Contracept Reprod Health Care 16 2011 444 457
28. D.A. Grimes, K.F. Schulz, and E.G. Raymond Surrogate end points in women's health research: science, protoscience and pseudoscience Fertil Steril 93 2010 1731 1734
29. J. Endrikat, S. Parke, D. Trummer, M. Serrani, I. Duijkers, and C. Klipping Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study Contraception 2012 10.1016/j.contraception.2012.07.008 pii: S0010-7824(12)00674-9
30. V.T. Martin, and M. Behbehani Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis - part 2 Headache 46 2006 365 386
31. P.L. Durham, C.V. Vause, F. Derosier, S. McDonald, R. Cady, and V. Martin Changes in salivary prostaglandin levels during menstrual migraine with associated dysmenorrhea Headache 50 2010 844 851
32. L.K. Mannix, V.T. Martin, and R.K. Cady Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials Obstet Gynecol 114 2009 106 113
33. J. Marjoribanks, M. Proctor, C. Farquhar, and R.S. Derks Nonsteroidal anti-inflammatory drugs for dysmenorrhoea Cochrane Database Syst Rev 1 2010 Jan 20 CD001751
34. A. Lethaby, C. Augood, K. Duckitt, and C. Farquhar Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding Cochrane Database Syst Rev 4 2007 Oct 17 CD000400
35. X. Ruan, H. Seeger, and A.O. Mueck The pharmacology of dienogest Maturitas 71 2012 337 344
36. 2 production in human endometriotic stromal cells in spheroid culture Fertil Steril 97 2012 477 482
37. I.S. Fraser, J. Jensen, M. Schaefers, U. Mellinger, S. Parke, and M. Serrani Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest Contraception 86 2012 96 101
38. L.J. Stovner, K. Aegidius, and M. Linde Endometriosis and headache Curr Pain Headache Rep 15 2011 415 419
39. A.H. Calhoun Menstrual migraine: update on pathophysiology and approach to therapy and management Curr Treat Options Neurol 14 2012 1 14